Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages

Azzazy, 2003, B-type natriuretic peptide: physiological role and assay characteristics, Heart Fail Rev, 8, 315, 10.1023/A:1026182912461 Dhingra, 2002, Brain natriuretic peptide: role in cardiovascular and volume homeostasis, Semin Nephrol, 22, 423, 10.1053/snep.2002.35666 Gerbes, 1994, Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues, J Clin Endocrinol Metab, 78, 1307, 10.1210/jc.78.6.1307 Rudiger, 2006, Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure, Crit Care Med, 38, 2140, 10.1097/01.CCM.0000229144.97624.90 Charpentier, 2004, Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis, Crit Care Med, 32, 660, 10.1097/01.CCM.0000114827.93410.D8 Papp, 2003, Myocardial function and haemodynamics in extensive burn trauma: evaluation by clinical signs, invasive monitoring, echocardiography and cytokine concentrations. A prospective clinical study, Acta Anaesthesiol Scand, 47, 1257, 10.1046/j.1399-6576.2003.00235.x Tanaka, 2004, Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes, J Int Med Res, 32, 57, 10.1177/147323000403200109 Ma, 2004, Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase, J Mol Cell Cardiol, 36, 505, 10.1016/j.yjmcc.2004.01.001 Vollmar, 1996, Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide, Endocrinology, 137, 1706, 10.1210/en.137.5.1706 Vollmar, 1995, Expression and differential regulation of natriuretic peptides in mouse macrophages, J Clin Invest, 95, 2442, 10.1172/JCI117944 Billack, 2006, Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B, Am J Pharm Educ, 70, 102, 10.5688/aj7005102 Shen, 1996, Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1, Free Radic Biol Med, 21, 139, 10.1016/0891-5849(96)00019-6 Zannetti, 1997, Phosphatidylinositol- and phosphatidylcholine-dependent phospholipases C are involved in the mechanism of action of atrial natriuretic factor in cultured rat aortic smooth muscle cells, J Cell Physiol, 170, 272, 10.1002/(SICI)1097-4652(199703)170:3<272::AID-JCP8>3.0.CO;2-L Pixley, 2001, Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages, Mol Cell Biol, 21, 1795, 10.1128/MCB.21.5.1795-1809.2001 Babior, 1999, NADPH oxidase: an update, Blood, 93, 1464, 10.1182/blood.V93.5.1464 Beckman, 1996, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly, Am J Physiol, 271, C1424, 10.1152/ajpcell.1996.271.5.C1424 Dennis, 1995, Multiple forms of phospholipase A2 in macrophages capable of arachidonic acid release for eicosanoids biosynthesis, Adv Prostaglandin Thromboxane Leukotriene Res, 23, 75 Balboa, 2006, Oxidative stress and arachidonic acid mobilization, Biochim Biophys Acta, 1761, 385, 10.1016/j.bbalip.2006.03.014 Cabral, 2005, Lipids as bioeffectors in the immune system, Life Sci, 77, 1699, 10.1016/j.lfs.2005.05.013 Lin, 2007, A cytokine-mediated link between innate immunity, inflammation, and cancer, J Clin Invest, 117, 1175, 10.1172/JCI31537 Jones, 2000, Cellular signaling in macrophage migration and chemotaxis, J Leukoc Biol, 68, 593, 10.1189/jlb.68.5.593 Kapoun, 2004, B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation, Circ Res, 94, 453, 10.1161/01.RES.0000117070.86556.9F Klinger, 2006, Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells, Exp Cell Res, 312, 401, 10.1016/j.yexcr.2005.11.001 Stuehr, 1991, Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs, FASEB J, 5, 98, 10.1096/fasebj.5.1.1703974 Li, 1998, Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production, Biochem Biophys Res Commun, 253, 295, 10.1006/bbrc.1998.9729 Frein, 2005, Redox regulation: a new challenge for pharmacology, Biochem Pharmacol, 70, 811, 10.1016/j.bcp.2005.04.012 Vinten-Johansen, 2007, Inflammation, proinflammatory mediators and myocardial ischemia–reperfusion Injury, Hematol Oncol Clin North Am, 21, 123, 10.1016/j.hoc.2006.11.010 Izzi, 2007, Pharmacological and clinical applications of natriuretic peptides: accepted knowledge or changing views?, Curr Pharm Anal, 3, 195, 10.2174/157341207781369376 Strassmann, 1994, Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2, J Exp Med, 180, 2365, 10.1084/jem.180.6.2365 Oh-ishi, 1996, Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes, Eur J Pharmacol, 300, 255, 10.1016/0014-2999(96)00005-2 Harizi, 2002, Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions, J Immunol, 168, 2255, 10.4049/jimmunol.168.5.2255 Brandt, 2006, Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form, Clin Chem, 52, 82, 10.1373/clinchem.2005.057638 Lambeir, 2003, Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV, Crit Rev Clin Lab Sci, 40, 209, 10.1080/713609354 Mentlein, 1999, Dipeptidyl-peptidase IV (CD26) — role in the activation of regulatory peptides, Regul Pept, 85, 9, 10.1016/S0167-0115(99)00089-0 Boerrigter, 2007, Des-serine-proline brain natriuretic peptide 3–32 in cardiorenal regulation, Am J Physiol, Regul Integr Comp Physiol, 292, R897, 10.1152/ajpregu.00569.2006